A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes.
about
Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer.Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patientsCo-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.
P2860
A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A phase II study of postoperat ...... h positive pelvic lymph nodes.
@en
type
label
A phase II study of postoperat ...... h positive pelvic lymph nodes.
@en
prefLabel
A phase II study of postoperat ...... h positive pelvic lymph nodes.
@en
P2093
P1433
P1476
A phase II study of postoperat ...... h positive pelvic lymph nodes.
@en
P2093
Kazuhiko Ogawa
Kimihiko Ito
Kiyoshi Yoshino
Masahiko Takemura
Seiji Mabuchi
Tadashi Kimura
Takayuki Enomoto
Takeshi Yokoi
Yasuhiko Shiki
P304
P356
10.1016/J.YGYNO.2016.02.011
P407
P577
2016-02-13T00:00:00Z